2019 Digital Health Summit | DAY 1
Tuesday, January 8
Join the real titans of digital health that aren’t just capturing headlines and intrigue, but rebuilding healthcare—from mega-advancements in next-gen hospitalization and digital medicines to extraordinary growth in med-tech, big data, machine learning, AI and wearables
Welcome to the 10th Anniversary of The Digital Health Summit at CES. Strap yourself in for what promises to be two extremely informative, enlightening and entertaining days as we look at the technologies and experts most profoundly impacting consumer healthcare and the system that is continuously adapting to serve them.
We are kicking off this Summit with one of the industry’s boldest moves forward in digital health—propelling the patient to the epicenter of healthcare.
What if rather than staying in the hospital directly following a serious surgery, you were discharged to your home with a solution delivering the same physician and nursing oversight you’d receive at the hospital? And could this same solution be used to enable acute care and cancer patients to participate in critical clinical trials while receiving their most-needed therapies from the comforts of their own home?
This imminent total transformation of remote and home health care, fused with cutting-edge technology, is here, operational and scaling.
Our Power Panel, an extremely diverse mix of industry wizards and stakeholders, will convene to discuss how the seemingly impossible in healthcare is becoming a reality. Discover how their synergies are disrupting everything from hospital care to clinical trials resulting in accelerated groundbreaking cancer research and therapy development, more engaged patients, higher cost savings and astounding health benefits.
We are celebrating our 10th anniversary in a monumental way as we peer into the captivating future of healthcare.
We welcome to the stage one of digital health’s brightest minds, physician-scientist and innovator, Dr. Daniel Kraft. Boasting an incredible list of accolades, Dr. Kraft will share his unmatched expertise on the rapidly developing technologies of the past, present and future and their radical impact on biomedicine and healthcare.
Then joining Dr. Kraft on stage for a compelling discussion is key leadership from three of the most disruptive and significant digital health companies: FitBit, the global leader in consumer wearables, Akili Labs, a cutting-edge digital therapeutics company pioneering digital treatments though video games, and Verily, an Alphabet subsidiary focused on developing state-of-the-art tools to prevent, detect and manage disease.
Don’t miss this critical discussion on the unbounded future of digital healthcare as we unleash powerful innovation into the next decade.
For many stakeholders, the healthcare experience feels siloed and fragmented. Today’s landscape consists of critical assessments, treatment plans and care decisions made within a 7-14 minute patient and provider face-to-face interaction, giving only a fraction of the full-patient picture. It’s no wonder patients feel confined to the walls of the hospital for much-needed care.
And now, with the next decade of digital health upon us, the walls are being torn down. Patient-generated data collected from tech resources, such as in-home medical devices and wearables, are providing improved comprehensive, continuous and curated patient care programs.
We’ve convened three key stakeholders—a patient with type 2 diabetes, a provider who has designed and managed remote care programs, and a health technologist specializing in data workflows and analytics—for a personal and practical look at the exemplary value that patient-generated health data (PGHD) and digital health devices are offering when applied to remote and virtual care programs.
This robust conversation will also provide the audience with invaluable insights for implementing, scaling and engaging patients in data-driven remote care programs. Discover how healthcare’s productivity and ability will continuously improve personalized care with the exciting implementation of data, machine learning and remote care.
It’s the first day of the show and you’ll need your energy. Take a moment to refuel with coffee and some snacks! And there is no better time than to start meeting other rock stars in the room.
The next generation of smart, consumer goods offer unprecedented insights into individual health. Between sophisticated DNA analysis and its link to our sleep quality to cutting-edge hearables and medical-grade biometric-sensing textiles, rapid, personalized treatments are finally on the table and are changing the game.
Healthcare’s massive advances in DNA analysis are telling us a riveting new bedtime story, unveiling new layers of invaluable insights to our health and wellness from a category in which we’d least expect—sleep!
We’re already aware that genomic data exposes us to the new world of precision disease treatment while also revealing our predisposition to diseases such as cancer, depression and diabetes, but the latest developments links this analytic data to sleep science opening up a new world to explore.
Lead by one of the world’s most recognized and respected physicians, this exceptional panel of sleep, medical and lifestyle experts, will explore how big ‘sleep’ data and our DNA profiles have converged to spotlight sleep technology as a remarkable new tool for consumers in proactively managing their personal health.
The science of sleep just created a new level of consciousness…
When we think of hearing aids, we don’t typically associate them with transformative and mind-blowing technology, or even deem them worthy to watch in the world of Artificial Intelligence— yet roughly 48-million Americans*, or a fifth of the US, suffer from some degree of hearing loss. In light of this shocking statistic coupled with monumental and market-altering legal revisions, the floodgate of new opportunities has opened and new companies, new technology, and the creation of leading-edge hearables have emerged.
Next-gen hearing aids are delivering a vast new set of capabilities, including real-time biometrics, artificial intelligence, integrated voice assistance, audio enhancements and even fall detection. The stigma is changing. Hearables are not only becoming socially acceptable but desirable.
Lead by a global expert, leader and innovator in biosensors, nanosensors, optical and wearable devices as well artificial intelligence and machine learning, this inspired presentation will showcase how some of the last remaining archaic pieces of healthcare are rising to the challenge of today’s most groundbreaking advancements in technology, ultimately creating what will be the consumer’s progressive ‘sixth sense.’
* Statistic from Hearing Loss Association of America
12:30 PM Join the industry leader in mobile-to-mobile communications, as well as the sole purveyor of a HIPPA and HITECH compliant IoT Platform for this hot-ticket presentation where they’ll dive into their end-to-end solution. Watch as they demonstrate cutting-edge healthcare technologies from companies such as Hanger and Medtronics, and get an exclusive glimpse into AT&T’s emerging communications that are enabling a new-age innovation—the FIRST of its kind.
12:45 PM Lunch will be hosted by Living in Digital Times, Producers of The Digital Health Summit.
Is twilight approaching for chronic disease? Diabetes, heart disease, cancer and the opioid crisis are being attacked in health tech’s surge. With the dawn of medical-grade genomics data, neuromodulation and medical wearables, tomorrow’s physicians will treat disease in whole new ways.
This national epidemic is a recurring headline, and it’s killing more than 115 people a day in the US. Our healthcare system is in a frenzy to find an effective solution to halt the opioid crisis that has taken our nation by storm.
On this dark, dismal path of opioid abuse, dependence, and addiction, exists a bright light we refer to as Neuromodulation—an FDA approved medical technology that’s been effectively used since the 1990s to treat chronic pain, epilepsy, parkinson’s, chronic headaches, and more recently, sleep apnea, depression, and substance abuse. Neuromodulation is the largest growing space in healthcare with a massive surge in spending, increasing from $1.5 billion to $3.7 billion over the last 5 years. The capabilities of this technology are colossal as resources are continuously poured into its further advancement and evolving functionality.
These discreet, implantable neural devices have the powerful capability of intervening in the adoption of opioids by confronting the root of the cause—PAIN. Even more remarkable is the ability of this technology to integrate with the consumer’s daily routines and interact with the world of IoT, the network in which we are exchanging data between the industry’s greatest technology like wearables, voice tech and more.
We’ve convened an impressive power panel to include the four largest global medical device enterprises, as well as the North American Neuromodulation Society whose mission is to promote collaboration across multiple disciplines. Together they will engage us in a provocative and inspiring conversation on how this proven solution is poised to make an everlasting impact in this state of medical emergency.
Healthcare professionals and tech-innovators alike are racing to find the answer to this fundamental yet profound challenge we face in the age of digital health: How do we increase consumer engagement to ultimately change behaviors?
Creating healthy habits is a powerful first line of defense in treating chronic disease, yet it’s presented a quagmire for even the largest, smartest, and most influential companies in the world.
We’ve invited a forward-thinking company who drew on their extensive background in consumer behavior and healthcare to develop a unique patient-provider platform to engage and empower patients with straightforward, turn-by-turn (aka waypoint) directions to improve their health — building simple, memorable and actionable habits over time.
Listen in to hear how their unique approach is proving to the world that keeping it simple may just be the silver bullet to disease.
Imagine having the power to collect, own and share your comprehensive healthcare data—from your historical-to-current medical records and fitness tracking data to your Genetic DNA results and biometrics from wearables—and furthermore, imagine this information being easily stored in ONE secure place in which YOU have complete control. For us digital health geeks, that sounds like an improbable dream.
We invite you to listen closely as Ardy Arianpour, the CEO of Sequester and recently announced 2018 Winner of Singularity University’s Exponential Medicine’s Medy Award reveals and demonstrates their astounding solution that many thought simply could not be accomplished.
The latest leading-edge developments in digital therapeutics are rapidly progressing healthcare’s approach to chronic disease management, particularly with behavior-related diseases such as diabetes.
With an approach that tackles what most innovators and clinicians tend to overlook as an imperative to obliterating Type 2 diabetes, we’re uncovering a solution that not only supplements current pharma protocols but can ultimately lead to eliminating the need for ongoing medications. The results are seismic as the technology reveals remarkable momentum in controlling, halting and even reversing Type 2 diabetes.
Bringing us this laser-focused technology is the founder and CEO of a company still flying under the radar. Discover the powerful results in his mission to combat this chronic disease!
The exploding industry of wearables has cultivated a healthcare landscape that is overflowing with vital data across a wide range of specialties. Among the most notable of these advancements are mobile EKG devices equipped with hospital-grade horsepower. The abundance of information available from technologies such as this are revealing invaluable heart health insights beyond the confines of the physician’s office.
We’ve invited one of the industry’s leading heart health CEO’s along with the Past President of Heart Rhythm Society to share the formidable tech advancements being made in heart health and to discuss the elephant in the room: How will physicians integrate this abundance of new data into their already pushed-to-the-max workflow to create life saving health managing strategies?
The shift is happening right before our eyes. Our healthcare system is moving from sick care to well care—something we weren’t sure would ever happen. And while prevention in healthcare can very simply mean that with proper self-care and health management, we have the power to stop certain ailments or sickness from occurring or worsening—that only goes so far. When prevention is interfaced with exceptionally advanced technology, results can break boundaries in providing earlier diagnosis, amplified proactive measures, and improved care and connection with the patient throughout the journey.
Joining us today are three of the most notable healthcare companies harnessing the mega powers of innovation to redefine the notion of ‘prevention’ entirely, with technology at the core to their competency. This impressive panel of leading global authorities include tech and health giant Philips, medical device and healthcare pioneers Johnson & Johnson, and Teladoc, the global leader in virtual care and telemedicine.
That afternoon lull might be starting to kick-in. Grab a drink and some eats to boost your energy and fuel your minds because you won’t want to miss these next sessions featuring digital health technologies poised to impact the next decade in monumental ways.
Voice tech, machine learning, AI, ingestibles, VR, wearables…with today’s flurry of promising healthcare technology, how do we separate hope from hype? Which ones can transform clinical trials, hospitals, pharma and consumer health? In this two-part series, the who’s who of digital health will reveal breakthroughs that deserve the spotlight.
We kick off this look into the future with an extreme close-up of two of the most significant innovations to impact healthcare: voice tech and wearables. And while the headlines sound trendy and flashy, the mission to integrate these technologies into new and transformative tools will face many challenges and obstacles—especially in highly-regulated industries like pharma.
The prevailing conversation of how we can use this influx of highly personalized data to improve patient outcomes and physician decision making, inevitably opens a Pandora’s Box of security and privacy concerns. The question begs to be answered — how will these industries be permitted to use the information streaming in to build, develop and launch superior solutions and medicines?
To help give you real-world tangible insights, examples and strategies, we’ve invited the largest worldwide manufacturer of generic pharmaceuticals, Teva, along with the world’s leading data and insights consultancy company, Kantar Health, for an informative discussion on how we will confront the challenges to expose the infinite and awe-inspiring possibilities ahead.
Though wearable devices are booming in tech-popularity, they don’t always make sense for a consumer’s everyday lifestyle or occupation. Plus, there is so much more that can, and should, be sensed than a wearable device can capture.
There has been an ongoing movement to increase consumer passivity in tracking important health metrics and one of the most promising is the world of ingestibles. Yes, it’s a very tiny sensor that can be swallowed to track and monitor from the inside like never before.
While ingestibles can be used for more general health and wellness tracking, the most exciting application allows for detection of disease or other conditions such as gastrointestinal disorders, something one in twelve Americans suffer from.
So bon appétit—it’s time to eat the sensor.
In recent years, we have all witnessed companies such as Amazon and Google see staggering success in the consumer adoption of voice tech-driven devices. And now, we’re rolling out the red carpet as we witness this technology invade the healthcare industry.
The aptitude of voice tech and it’s ability to identify vocal biomarkers is poised to radically change healthcare, much in the same way as radiologic imaging enabling clinicians to see inside a human body!
To lead this discussion, we’ve invited one of the industry’s leading analysts whose 2018 Innovation Report recognized the untapped potential of voice-first as one of the most capable technologies to not only serve as a catalyst to enhancing traditional healthcare, but also to possess an uncanny ability to assist seniors.
And joining this compelling 1:1 is the President and Co-Founder of Orbita, the company uprooting the market with the only enterprise-grade, conversational platform that is powering HIPAA-compliant voice and chatbot applications in healthcare. Impressively, Orbita is collaborating with some of the country’s most digitally savvy healthcare organizations to design, build and deploy virtual assistants across consumer, business and clinical applications.
Welcome to a “talkative” future where the sound of our voice will catalyze an industry.
When the largest nonprofit hospital in the Western United States needed to implement technology solutions to solve some of their greatest challenges, they knew it would take a lot more than just identifying and purchasing existing innovations in the market.
Differentiated by a hyper-customized approach, this massive hospital-tech overhaul identifies innovators best suited to resolve a particular issue who then work side-by-side with the hospital’s physicians, administrators and others to develop, refine and implement the most effective solutions. This “Living Lab” concept establishes purposeful integration of leading-edge technologies with the hospitals day-to-day operations, authentically improving patient care and also cuttings costs for physicians and nurses.
This unique talk will showcase how Cedars Sinai Accelerator has successfully collaborated with tech’s most impressive innovators to launch remarkable new solutions and will continue to catalyze the future of hospital optimization.
Rising costs, unpredictable timelines, patient recruitment, and patient adherence–just a few of the tremendous challenges clinical trials face to be successful.
Pharma companies continue to face these never-ending, insurmountable financial and reputational pressures and are BEGGING for a more efficient, cost-effective solution to this critical stage of drug development. Not surprisingly, they are actively investing in leading-edge technologies to yield this competitive edge.
We’ve invited the Head of Digital Health and MedTech from a global leader in innovation to share her powerful insights on how technology—more specifically, data analytics, device and wearable connectivity, blockchain, and AI—will intervene and transform the clinical trials of yesterday into “well-oiled machines” for superior drug development and next-gen treatments for disease.
We’ve invited one of Digital Health’s most prolific CEO’s to deliver our closing keynote of Day One. Discover how the integration of health tech into a well-known consumer brand is not only driving and changing behaviors, but also revealing how highly-accurate data will fuel the future of sleep health.
2019 Digital Health Summit | DAY 2
Wednesday, January 9
The health revolution is here. Stable growth, astounding technology, expanded patient options and a giant shift in retail are just some of the changes we’re living. Discover how today’s most impressive companies are adapting and prospering straight from the C-Suite.
Welcome to day two of the 10th Annual Digital Health Summit at CES. Anticipate another day filled with informative and highly-compelling discussions from top experts in digital health, healthcare, technology, journalism and more.
Session description coming soon.
In today’s digital age, an abundance of resources provide us with unprecedented insights into our health—from smart watches and trackers to sensors and apps. Despite the wealth of information available, actually changing our behavior to maximize the data at our fingertips has become a complex challenge. How to overcome this roadblock continues to raise questions as it remains at the forefront of initiative.
How do we create even more hyper-personalized health technology solutions that continuously engage consumers? How can we integrate the latest advancements in technology, such as artificial intelligence, to make solutions even smarter while also augmenting consumers’ capabilities?
Hear first-hand how global health technology company Philips is reframing this industry-wide barrier using a refreshed take on their design principles. Sean Carney, Philips’ Chief Design Officer, will elaborate on how their team of experts have created seamless experiences for consumers and medical professionals that extend well-beyond performance and functionality, further engaging and motivating users to achieve more consistent use.
Did you take too much advantage of Las Vegas’ nightlife perhaps? Have a minor headache that just won’t go away? Well it’s lucky for you that we have some coffee ready for you! Grab yourself a cup because, as you know, coffee contains caffeine which happens to brilliant at relieving your headache. Oh, and while your there filling up, introduce yourself to someone new. You’ll be surprised who you might meet.
Healthcare is taking retail on a wild ride. Big-box retailers are jumping into this meeting-of-markets, and other companies will follow. Retailer “newcomers” are helping consumers bypass traditional healthcare channels to acquire the tools they need, including hearing aids and orthodontics.
With suicides making year-round headlines and skyrocketing Alzheimer’s rates, everything’s not okay with our state of mind. But it’s far from hopeless. Digital innovators have developed life-saving therapeutics and other wonders helping those suffering from these and other tragic conditions.
It affects 1 in 10 Americans over 65. It ravages both mind and body. It is terminal. Alzheimer’s disease is arguably the greatest health care challenge of the present era, as well as the nation’s largest, looming financial sinkhole. Costs to taxpayers could rise as high as $1 trillion by 2030, from an already eye-watering $277 billion today.
In our relentless pursuit to discover a cure to this awful disease, pharma continues to fall short with no promising path to success. So it’s no surprise that technology is rising to the challenge. With technology being so instrumental in so many facets of healthcare, how will it confront this disease head-on?
This timely and critical discussion brings together some of today’s most successful technology innovators making massive impacts in the treatment and management of this daunting disease. Addressing some of Alzheimer’s greatest points of pain are their inventions, including the first FDA-approved digital therapeutic for Alzheimer’s, a VR-enabled learning system for caregiving, a life-like robotic pet to help those living with cognitive decline, and a transformative care management solution that addresses the professional care team, the family caregivers and the patient.
Leading this discussion is our special guest, Richard Lui, recognized not only for his career as a Journalist and News Anchor for MSNBC and NBC; but also as a notable speaker on the topic of caregiving, who shares his own insights and personal journey in caring for his father suffering with Dementia. Please join us for this moving, impactful and newsworthy conversation.
We’ve heard all the statistics—the elderly population within the US is anticipated to increase by 80 percent over the next 25 years, placing a massive burden on our healthcare system and an unprecedented need to address the growing concerns with this most vulnerable segment of our population.
And while innovators have moved forward to deliver solutions, the dawn of voice-tech and AI will be an unquestionable gamechanger as the combined technologies promise to upset the vicious cycle that seniors face: healthcare issues that lead to extreme isolation, causing depression and compounding health issues.
Led by FeibusTech’s CEO and USA Today contributor, Mike Feibus, this eye-opening discussion will address how today’s most groundbreaking tech has the power to prevent a senior’s health crisis by providing proactive data to both patients and caregivers, while also tackling the imperative issue of isolation.
Originally launched at CES’ Digital Health Summit in 2014, Muse® quickly became the world’s bestselling consumer neurotechnology device. As a neuroadaptive brain-computer interface, they’ve empowered people around the world to improve their understanding of their own brains, and access techniques and tools to improve their brain health.
Now in 2019, Muse® is back— pushing the boundaries of neurotechnology yet again. By integrating AI, biometrics and informatics specifically developed for large-scale brain data into their latest technology development, they’re enabling consumers to achieve peak brain performance through an improved relationship with their bodies and minds.
And the benefits extend well beyond the consumer. Scientifically validated brain data metrics are being taken out of the lab and enabling athletes, scientists, clinicians and hackers the ability to apply this radical research to real-world neuroscience, teaching, and learning.
Witness the future of consumer-accessible neurotechnology live from our stage as Muse® returns for a session that may just actually blow your mind!
The frontiers of healthcare are expanding yet again, and the boundaries are limitless as we venture to outer space with one of the nations most elite organizations – NASA. Discover how the findings from space exploration are being leveraged to uncover new methods to mitigate some of healthcare’s greatest challenges, including incurable diseases like arthritis and osteoporosis.
The colossal transformation of healthcare and its relationship with technology is continuing to break boundaries in its exploration of new and exciting territories, including the most extreme one yet—outer space!
On the frontlines of medicine is Dr. Aenor Sawyer, NASA’s Chief Health Innovation Officer for the Translational Research Institute for Space Health, leading us in this riveting conversation showcasing how an extreme environment such as outer space effects the human body, and how that information can be leveraged to make astronomical advancements in healthcare.
Bringing to the conversation his profound experiences as a NASA Astronaut, and as Senator John Glenn’s physician, is current tech entrepreneur Scott Parazynski. As a veteran of 5 space shuttle flights and 7 spacewalks, listen closely as he shares insights to his exploration of the parallels that exist between outer space and healthcare, and the gravity that this research will have in producing new real-world solutions.
It’s time for that highly critical time in the day where you get out of your seats to get that blood flow going, you grab that “pick-me-up” you need for energy, and you introduce yourself to that one person you’ve been dying to chat with the entire Summit. From now until our party at the end of the day, we’ll be showcasing some of today’s most impactful technologies so your brains need to be tip-top so you can take it all in!
In part two of this series, we’ve invited the who’s who of digital health to reveal the promising future of blockchain, digital therapeutics, ingestibles, robotics and sensors. Witness the future as they reveal the breakthroughs that deserve the center-stage spotlight.